Genetic variants of miRNA sequences and non-small cell lung cancer survival.

By Zhibin Hu, Jiaping Chen, T. Tian, Xiaoyi Zhou, H. Gu, Lin Xu, Yi Zeng, R. Miao, G. Jin, Hongxia Ma and 2 more. Journal of Clinical Investigation, 2008

615 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/0652792ce0a5d286fa216df938541ce288cb8529

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

In Molecular Biology

Citations in the corpus

Genetic variation in microRNA networks: the implications for cancer research (2010, neutral): “Notably, this SNP has also been associated with poor survival in patients with lung cance”
MicroRNAs in cancer: small molecules with a huge impact. (2009, background): “MiRNA expression can be altered by several mechanisms in human cancer (Fig 3): chromosomal abnormalities, as suggested by the evidence that microRNAs are frequently located in regions of the genome involved in alterations in cancer,(4) and recently confirmed by a genetic study in ovarian carcinoma, ”
Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. (2010, methodology): “Patient characteristics and clinical features were partly described previously.(16) To control disease heterogeneity, only patients with stages I to IIIa lung cancer with adenocarcinoma and squamous cell carcinoma treated with both surgical operation and adjuvant chemotherapies were included on this”